Yan Guang-li, Sun Hui, Zhang Ai-hua, Han Ying, Wang Ping, Wu Xiu-hong, Meng Xiang-cai, Wang Xi-jun
Zhongguo Zhong Yao Za Zhi. 2015 Sep;40(17):3406-12.
Serum pharmacochemistry of traditional Chinese medicine (TCM) is designed to screen the efficacy material base of TCMs from the constituents absorbed into the blood after oral administration. The theory and method is in accordance with the effect characteristics of TCMs, and reflects the interaction between the body and the drugs, has become an effective pathway for researching the efficacy material base of TCMs which has been recognized and used widely. In the paper, the previous research contents and methods of the serum pharmacochemistry of TCM were reviewed, and on the basis of the further validity of the special administration form of the TCM formula and the corresponding property to TCM syndrome, the new strategy of serum pharmacochemistry of TCM integrating the metabonomics technologies was put forward. According to the strategy, we take the biological characters of TCM syndrome as a research starting point, taking TCM formula as object, using the metabolic biomarkers of syndromes or disease to evaluate the therapeutic effect of formula and screen the compounds of TCMs in serum which are highly correlated with the metabolic biomarkers through the correlation analysis, and by further biological validation to finally confirm the efficacy material basis of TCMs. Integrating with the systems biology technologies, the theory and method of serum pharmacochemistry of TCM will further develop, and open a new chapter in the interpretation of the theory of TCM.
中药血清药物化学旨在从口服给药后吸收入血的成分中筛选中药的药效物质基础。该理论和方法符合中药的作用特点,反映了机体与药物之间的相互作用,已成为研究中药药效物质基础的有效途径并得到广泛认可和应用。本文回顾了以往中药血清药物化学的研究内容和方法,并在进一步验证中药复方特殊给药形式及其与中医证候相应性的基础上,提出了整合代谢组学技术的中药血清药物化学新策略。按照该策略,以中医证候生物学特征为研究起点,以中药复方为研究对象,用证候或疾病的代谢生物标志物评价复方疗效,通过相关性分析筛选血清中与代谢生物标志物高度相关的中药化合物,经进一步生物学验证最终确定中药药效物质基础。与系统生物学技术相结合,中药血清药物化学的理论和方法将进一步发展,为阐释中医理论开启新篇章。